Akari Therapeutics Plc: Akari Therapeutics, Plc Announces $4 Million Registered Direct Offering

Offering includes 100% participation by Akari's Board of Directors, including Akari President and CEO Rachelle JacquesOffering includes accredited investors who have not previously participatedDefinitive

Related Keywords

London ,City Of ,United Kingdom ,Donalda Wojnowski Jr ,Mike Moyer ,Eliza Schleifstein ,Rachelle Jacques ,Ray Prudo ,Nasdaq ,Exchange Commission ,Paulson Investment Company ,Akari Therapeutics Plc Nasdaq ,Akari President ,Akari Board ,American Depository Shares ,Investment Company ,Orphan Drug ,Fast Track ,Rare Pediatric Disease ,Private Securities Litigation Reform Act ,Annual Report ,Hakari ,Herapeutics ,Nnounces ,Billion ,Registered ,Direct ,Offering ,